Rokos Capital Management LLP Sangamo Therapeutics, Inc Transaction History

Rokos Capital Management LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $5.72 Million - $12.7 Million	3,448,138 Added 113.94%	6,474,348 $11.4 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $6.72 Million - $12.7 Million	2,048,547 Added 209.54%	3,026,210 $12.5 Million
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $2.29 Million - $3.42 Million	437,803 Added 81.1%	977,663 $5.86 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $4.86 Million - $6.48 Million	539,860 New	539,860 $4.95 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Rokos Capital Management LLP with notifications on news.